• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

BL-1249 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5754622

BL-1249 is a nonsteroidal anti-inflammatory drug (NSAID) and a potassium channel activator. BL-1249 exhibits more selective for the bladder (EC50 of 1.26uM) than vascular tissue (EC50 of 21.0uM). BL-1249 extracellular application activates all TREK subfamily… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
BL-1249, Inhibitor
Full Product Name
BL-1249
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
291.35
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C17H17N5
SMILES
C1(NC2=C3CCCCC3=CC=C2)=CC=CC=C1C4=NN=NN4
CAS Number
18200-13-0
Target & IC50
TREK-1: ic50 5.5uM (EC50)
TREK-2: ic50 8.0uM (EC50)
In Vitro
BL-1249 (1mg/kg) inhibits isovolumic bladder contractions in vivo. BL-1249 (1mg/kg) has little effect on mean arterial blood pressure, an observation again consistent with the in vitro bladder to vascular relaxant selectivity[1]. The short duration of the effect of BL-1249 on bladder contraction (30 min) is likely due to a fast elimination half-life of the compound after i.v. administration (0.69 h)[1].

Structure of BL-1249, inhibitor

BL-1249 Inhibitor – Cat# MBS5754622

Product References and Citations for BL-1249, inhibitor

Tertyshnikova S, et al. BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: a putative potassium channel opener with bladder-relaxant properties. J Pharmacol Exp Ther. 2005 Apr;313(1):250-9.
Tertyshnikova S, et al. BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: a putative potassium channel opener with bladder-relaxant properties. J Pharmacol Exp Ther. 2005 Apr;313(1):250-9.
Pope L, et al. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K2P Channels. ACS Chem Neurosci. 2018 Dec 19;9(12):3153-3165.
Pope L, et al. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K2P Channels. ACS Chem Neurosci. 2018 Dec 19;9(12):3153-3165.
Iwaki Y, et al. Towards a TREK-1/2 (TWIK-Related K+ Channel 1 and 2) dual activator tool compound: Multi-dimensional optimization of BL-1249. Bioorg Med Chem Lett. 2019 Jul 1;29(13):1601-1604.
Iwaki Y, et al. Towards a TREK-1/2 (TWIK-Related K+ Channel 1 and 2) dual activator tool compound: Multi-dimensional optimization of BL-1249. Bioorg Med Chem Lett. 2019 Jul 1;29(13):1601-1604.

Other Notes

Small volumes of BL-1249, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for BL-1249 purchase

MBS5754622 is an inhibitor targeting BL-1249.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000